September 24, 2019
Global Methicillin-resistant Staphylococcus aureus (MRSA) drugs market to surpass $ 1.3 Billion by 2026
According to Coherent Market Insights, the global methicillin-resistant Staphylococcus aureus (MRSA) drugs market is estimated to be valued at US$ 922.2 million in 2018, and is projected to exhibit a CAGR of 4.1% over the forecast period (2018–2026).